Best Hip Braces: What the Research Actually Supports (and What It Doesn’t)
Table of Contents
Introduction: Best Hip Braces
Hip, lower-back, and buttock pain are common reasons for consultation in my clinical work, and these symptoms can have a substantial impact on daily life. I encounter them in people with very different physical demands, including those who spend much of the day sitting and those whose work involves prolonged standing. Lateral pain around the greater trochanter is another recurring presentation, and patients may interpret it as “sciatica” even when the sciatic nerve is not necessarily the source.
Patients sometimes ask whether a back or hip brace might help. It is a reasonable question, but searching for the “best hip brace” can create the misleading impression that every hip problem responds to the same type of support. It does not. The available research is fragmented by condition and brace design: some products have limited condition-specific evidence, others remain essentially unstudied, and routine bracing after hip arthroscopy has failed to improve outcomes in a randomized trial.
This article therefore evaluates hip braces category by category, focusing on what the published research actually supports rather than relying on product ratings or marketing claims. Where the evidence is small, industry-funded, or absent, I state that directly. The aim is to help you identify which products have at least some relevant research behind them—and avoid spending money on a brace that is unlikely to address your particular problem. For a broader explanation of how these devices work, the designs available, and their general advantages and limitations, see my companion article on hip braces.
Some of the links on this site are affiliate links. If you purchase a product through these links, I may earn a commission. This doesn’t cost you anything, but it helps me maintain this page so I can continue to share free information with the world. As an Amazon Associate, I earn from qualifying purchases. Product links are provided for informational and convenience purposes only. Their inclusion does not constitute medical or nutritional advice or a personalized recommendation.
The Best Hip Braces for Sacroiliac (SI) Joint and Pelvic Girdle Pain
This is the category with the most direct evidence for a hip brace — but it comes from two separate, industry-funded bodies of research testing two different products, and that funding needs to be on the table before either pick.
Bauerfeind SacroLoc Hip Brace
The product studied in the independently-conducted (though Bauerfeind-funded) SI-belt trial below — six weeks of measurable quality-of-life improvement, though same-day pain relief wasn’t statistically confirmed.

| Pros | Cons |
| Reviewers frequently describe it as comfortable, low-profile, and easy to wear under clothing | Sizing runs tight for some — several reviewers report visible bulging or discomfort when between sizes |
| Many report it stays securely in place during activity (yoga, biking, daily wear) | A few describe it as too stiff/structured for genuinely continuous all-day wear |
| Study: documented quality-of-life improvement at 6 weeks | Study: same-day pain relief not statistically confirmed (small, n=17) |
What buyers say. Reviews for the SacroLoc are largely positive on comfort and discretion — several long-term wearers describe it as low-profile enough to forget they’re wearing it, and effective for specific activities like biking or yoga. The most consistent complaint is sizing: multiple reviewers report it running small, with a visible bulge (“muffin top”) or discomfort when the wrong size is chosen, and a few say it’s too structured for genuinely all-day wear even when sized correctly. This isn’t systematic data — it’s what surfaced in the search snippets available for this piece, not a formal survey — but it’s broadly consistent with what the research below would predict: a real, moderate effect for some wearers, not a universal fix.
The Bauerfeind SacroLoc evidence. A case-control study compared 17 patients with confirmed SI joint pain (not pregnancy-related — pregnancy was explicitly an exclusion criterion) to 17 healthy controls, testing the Bauerfeind SacroLoc hip brace [1]. Patients showed significant improvement in physical-health quality-of-life scores (SF-36) at six-week follow-up. Rectus femoris muscle activity was significantly reduced under moderate belt tension (p=0.02 vs. controls) — though this difference disappeared under maximum tension — while gait cadence and velocity improved significantly under maximum tension specifically. Pain scores (NRS) dropped significantly on the exam day compared to the two weeks prior — but the authors themselves note this initial drop may reflect the effect of simply being examined or patients’ expectations, not the brace specifically; comparing belt-on to belt-off conditions on the same day showed no statistically significant pain difference, and the authors state the sample was underpowered to detect one.
Funding: Bauerfeind AG provided financial and material support; per the published disclosure, the funder had no role in study design, data collection, analysis, or the decision to publish.
Serola Sacroiliac Belt
The product tested in both Serola-funded studies below — rated higher for satisfaction than a comparator lumbar brace, though not shown to outperform going without a brace at all.

| Pros | Cons |
| Long-term users (some 10+ years) report consistent comfort and reliable all-day wear | Correct positioning matters — one reviewer reported constipation from wearing it too tight/high before learning proper placement |
| Reviewers describe it as low-profile and easy to adjust throughout the day | Study: funded by Serola directly, with a $20,000 payment and manuscript-approval rights |
| Study: rated significantly higher for satisfaction than a comparator lumbar brace | Study: no significant advantage over the comparator brace in pain, disability, or analgesic use |
What buyers say. Serola reviews skew strongly positive, with a number of long-term users — some reporting years, even over a decade, of regular wear — describing consistent comfort and reliable all-day support, including during running, travel, and physically demanding days. One notable caution surfaced in the search: proper placement matters, and one reviewer specifically described constipation from wearing the belt too tight and too high before learning correct positioning — a practical detail the trial data alone wouldn’t capture. As with the SacroLoc, this is impressionistic review evidence, not a formal outcome measure, but it’s broadly consistent with the modest, real effect the studies below describe.
The Serola belt evidence. Two smaller studies specifically tested the Serola Sacroiliac Belt, and both were funded by Serola Biomechanics. A crossover RCT (n=30 after exclusions) had chronic low-back-pain patients wear the Serola hip brace for one week and a Horizon 627 lumbar brace for another [2]. (For general lumbar-brace evidence on this comparator device, see my separate review of back braces.) The Serola belt scored significantly higher on a user-satisfaction measure (QUEST, 20.31 vs. 16.17, p=0.0375) — but there was no significant difference between the two braces in pain, functional disability, or analgesic use. In plain terms: this trial shows the Serola belt was preferred over one specific competitor, not that either hip brace outperformed no brace at all.
Funding: Serola Biomechanics paid $20,000 to two of the study’s authors to cover brace purchase and data collection, and the disclosure states that Serola approved the manuscript before submission — a materially closer funder relationship than the Bauerfeind study above.
A separate single-session study enrolled 48 college students in three groups — 16 without low back pain and no belt, 16 with low back pain and no belt, and 16 with low back pain who wore the Serola belt — during a 10-minute manual-labor simulation [3]; lower-back discomfort on a symptom questionnaire improved significantly in the belt group (p=0.002) while worsening slightly but non-significantly in the no-belt group, though the more standard pain-rating-scale result didn’t reach significance (p=0.070), the sample was a convenience sample of college students (not representative of typical hip brace buyers), and a post-hoc power analysis found the study underpowered (power=0.604). Serola provided what the authors describe as “nominal funding” for this study.
Neither Serola study is disqualifying — modest, honestly-reported findings from industry-funded pilot research are common and not inherently untrustworthy — but a reader choosing between these two real hip braces deserves to know that the two most Serola-specific results came from Serola-funded work, with a $20,000 payment and a disclosure stating that Serola approved the manuscript before submission, while the Bauerfeind-funded study disclosed no funder role in design, analysis, or publication decisions and reported a genuinely negative population-level pain finding built in — a real difference in the closeness of the funder relationship, even though both studies were industry-funded.
Research is intended to be objective, but funding relationships still matter. A manufacturer-funded study is not automatically unreliable, and industry support is often necessary to study a specific commercial device. Even so, financial ties can influence which questions are investigated, how studies are designed, which outcomes receive emphasis, and how the results are interpreted. In my view, this does not mean that manufacturer-funded research should be dismissed; it means that its conclusions deserve closer scrutiny, particularly when the evidence comes from a single small study and has not been independently replicated.
This is why I have included the funding and competing-interest disclosures alongside the findings in this article. Peer-reviewed research generally provides far more useful information than unsupported claims on a product page because readers can examine the study design, methods, results, and stated limitations. Peer review, however, does not guarantee independence or eliminate bias. Manufacturer-funded evidence is therefore best treated as evidence with an important caveat—not as neutral confirmation of the manufacturer’s marketing.
Best Hip Braces for Lateral Hip Pain (“Trochanteric Bursitis”)
Most bracing for this condition is sold as if it treats “bursitis” — but that’s usually the wrong diagnosis, and no product here is evidence-backed as a treatment.
ROXOFIT Hip Brace / Compression Sleeve
A real, purchasable neoprene sleeve marketed for hip arthritis, bursitis, sciatica, and SI joint pain on one listing — included as a comfort option, not because any evidence supports it as treatment.

| Pros | Cons |
| Marketed as an affordable, adjustable option with separate fit zones for waist and thigh | Far less independently-verifiable customer review content available than for the two products above |
| Positioned for general use across many activities, not a single narrow indication | Third-party rating aggregators put it in the decent-but-unremarkable range (roughly high-3s to high-4s out of 5), not a standout |
| Study: none directly applicable | Study: no controlled evidence for any condition it’s marketed for; broad, unreferenced claims across unrelated diagnoses on the same listing |
What buyers say about ROXOFITT. This one’s harder to characterize with confidence. Unlike the two products above, the searches for this piece mostly turned up seller marketing copy and brand-level rating aggregators rather than substantial first-person Amazon review text. What’s there points to general satisfaction with fit adjustability and value for the price, but there isn’t enough independently-verifiable detail here to say much more than that — which is itself consistent with this being a comfort-category pick rather than one backed by either strong reviews or clinical evidence.
Why this category doesn’t get a real hip brace pick. What’s commonly labeled “trochanteric bursitis” is often not primarily a bursitis problem — a scoping review of the peritrochanteric space cites a large ultrasound series (877 hip ultrasounds performed for lateral hip pain) in which only 20% showed trochanteric bursitis, compared with nearly 50% showing gluteal tendinosis and 29% showing IT band thickening or tears [5]. Searching specifically for randomized or controlled trial evidence on external hip bracing or compression for this condition returned nothing that met that bar — only manufacturer product pages making broad, unreferenced claims about “reducing pain” across a long list of unrelated diagnoses, including the listing above and several similar neoprene hip/groin sleeves identified during the search. Some users may perceive a compression sleeve as comfortable, but that hasn’t been established by controlled research either — and management of confirmed gluteal tendinopathy commonly emphasizes education and progressive exercise rather than bracing. If you buy a sleeve anyway, treat it as a comfort measure, not a treatment.
Somewhat paradoxically, patients with clinically suspected trochanteric bursitis often describe the lateral hip as highly sensitive to direct pressure—for example, when lying on the affected side. In my clinical experience, compression over the painful area can also be uncomfortable. That does not establish how every patient will respond to a compression sleeve, but it does make the marketing logic somewhat counterintuitive: a product that applies pressure directly over an already pressure-sensitive area may not feel soothing at all. For someone whose main symptom is tenderness around the greater trochanter, comfort should not be assumed simply because a device is marketed as “compression support.”
The Best Hip Braces for Hip Osteoarthritis (Biomechanical Support)
This category ends without a product pick. Several small studies have evaluated hip OA braces since 2008, but the most relevant evidence for currently marketed devices—the Össur Hip Unloader and Bauerfeind CoxaTrain—remains based on small, manufacturer-funded studies without sham or no-brace intervention controls.
In my clinical experience in Finland, these braces are not a prominent part of routine conservative care, which more commonly focuses on symptom management and maintaining appropriate physical activity. They also require careful sizing, may warrant professional fitting, and can be expensive—the Össur listing identified during this research was priced in four figures.
Given the limited evidence and potentially substantial cost, I would not treat either device as a self-directed purchase. If you are considering one, discuss it with your orthopedist first. The research behind that conclusion follows below.
The Össur Hip Unloader evidence. A small repeated-measures study (n=14) tested a brace designed to reduce joint loading via external rotation and abduction force; nine of the fourteen participants reported an immediate reduction in pain while walking braced, and the brace produced a statistically significant decrease in peak hip abduction moment on the affected side [4]. It’s a single-session repeated-measures design (braced vs. unbraced, no sham brace) with no long-term follow-up.
Funding: fully funded by Össur hf, and one of the two authors was an Össur employee at the time.
The Bauerfeind CoxaTrain evidence. A study of 21 people with hip OA and 21 matched controls tested CoxaTrain over one week of real-world use [8]. Walking and night pain decreased significantly, while 6-minute-walk distance improved from 559.7 to 589.1 metres. However, the study was unblinded and lacked a sham or no-brace intervention control, and the absolute pain reduction remained below the cited threshold for clinical importance.
Funding: Bauerfeind provided financial and material support but disclosed no role in the study or publication decision.
A newer 2026 analysis of the same CoxaTrain cohort found that stair-walking pain decreased by 28% after one week, but the absolute reduction remained below the cited MCID threshold [9]. This was not an independent replication, and the study remained unblinded, uncontrolled, short-term, and manufacturer-funded; one author also reported a medical-advisory relationship with Bauerfeind. Overall, the Össur and CoxaTrain findings are encouraging but come from only two small cohorts and remain insufficient for a confident product recommendation.
Funding: Bauerfeind provided financial and material support but reported no role in the study or publication process; one author disclosed a medical-advisory relationship with the company.
Post–Hip Arthroscopy Bracing: Not Recommended Based on Current Evidence
No product recommendation follows from this section. If your surgeon hasn’t specifically prescribed a hip brace for a reason outside pain/function (e.g., a specific repair technique), routine bracing did not produce a measurable average benefit in this trial while adding the cost of the device — worth discussing directly with your surgeon rather than assuming either way. Here’s the trial behind that.
This is the clearest negative finding in the whole research set, and it’s worth stating plainly rather than working around it. A randomized controlled trial (n=82, Level I evidence) directly tested whether a hip brace helps after hip arthroscopy for femoroacetabular impingement syndrome (osteoplasty + labral repair) [6]. Patients were randomized to brace or no brace, worn full-time for three weeks. At the primary 6-week endpoint, mean pain scores (NPRS) did not differ significantly between the brace group (1.8) and no-brace group (2.3) — adjusted mean difference −0.5 (95% CI, −1.2 to 0.2; P=.17). No significant differences were found at 3 weeks or 6 months either, nor in functional outcome scores (HOOS), quality-of-life scores (VR-12), physical exam findings, or narcotic/injection use at the reported secondary follow-up timepoints — despite excellent self-reported brace compliance (mean 87%, median 95%) in the braced group. The trial’s own conclusion: patients who wore a hip brace after FAIS surgery did not experience less pain at 6 weeks than those who didn’t. An earlier conference-abstract version of this trial [7] additionally stated the authors “recommend against routine prescription of bracing after hip arthroscopy for FAIS,” citing the added cost with no demonstrated benefit — a line not confirmed here in the peer-reviewed full text (paywalled beyond the abstract), so treated as the earlier version’s wording rather than a verified quote from the final published paper.
In my clinical experience in Finland, hip braces are rarely used after routine hip arthroscopy. Finnish care tends to follow national evidence-based recommendations closely, and treatments without convincing supporting evidence are less likely to become standard practice. Individual surgeons may still recommend a brace in selected situations, but this appears to reflect case-specific judgment or clinical experience rather than an established routine supported by strong comparative evidence.
Comparison at a Glance: Best Hip Braces
| Category | Product | Evidence type | Funding disclosure |
| SI joint / pelvic girdle pain | Bauerfeind SacroLoc | Case-control, n=34, QoL benefit; pain result underpowered | Bauerfeind-funded; funder had no design/analysis/publication role |
| SI joint / pelvic girdle pain | Serola Sacroiliac Belt | Crossover RCT (n=30) + single-session study (n=48); satisfaction benefit, no significant pain advantage over comparator brace | Serola-funded; one study granted Serola manuscript approval |
| Lateral hip pain | ROXOFIT sleeve (comfort only) | No controlled evidence found | N/A — not a treatment claim |
| Hip osteoarthritis | Not recommended — see an orthopedist instead | Three publications based on two small manufacturer-funded cohorts (n=14, n=21); the two CoxaTrain publications analyzed the same one-week intervention, not independent replications | Össur fully funded [4], with one author employed by Össur; Bauerfeind provided financial and material support for [8][9], and one [9] author reported a medical-advisory relationship with Bauerfeind |
| Post-hip-arthroscopy | Not recommended | RCT (n=82), no benefit found | Full funding and COI details not independently extracted |
This table is a navigation aid, not a ranking — read the section above before buying, since “evidence type” hides a lot of nuance a single cell can’t carry.
Frequently Asked Questions About Hip Braces
Do hip braces actually work, or is it placebo? The honest answer is “possibly, in selected conditions — but the trials are small and all of the SI-belt studies are industry-funded, one more closely than the other.” The quality-of-life and gait improvements in the Bauerfeind-funded study (which disclosed no funder role in analysis or publication) are real findings, not nothing — but most of these studies weren’t blinded, so a placebo contribution can’t be ruled out, and none amounts to a large, independent, placebo-controlled trial showing pain relief from a hip brace on its own.
How tight should a hip brace be? The Bauerfeind SI-belt study specifically tested “moderate” versus “maximum” tension and found gait benefits were larger under maximum tension in that one study — but it didn’t compare long-term comfort or adherence between tension levels, so that finding shouldn’t be read as “tighter is always better.” Manufacturer sizing charts and fit instructions (available on each product page) are the more relevant guide for day-to-day wear; avoid any tension that’s painful or poorly tolerated.
Can I wear a hip brace all day? Most of the product-specific studies detailed in this article evaluated only an immediate response or one week of use — though the SacroLoc study followed patients for six weeks, and the older WISH-brace research line included considerably longer follow-ups. None of this establishes the benefits or risks of indefinite daily use — skin condition, circulation, fit, and your specific diagnosis all matter here, so this is worth asking your own clinician about rather than assuming it’s purely a comfort call.
Is a hip brace covered by HSA/FSA? Some orthopedic braces qualify as HSA/FSA expenses, but eligibility depends on the specific product, medical purpose, documentation requirements, and your individual plan — confirm with the seller and your plan administrator before assuming either way.
From a clinical perspective, I would not view a hip or pelvic belt as a permanent solution or a substitute for appropriate rehabilitation. In many hip and buttock pain presentations, active physiotherapy can become more important than passive support. Depending on the diagnosis and the person’s current tolerance, this may include carefully progressed isometric exercises, which are one option I sometimes use when introducing or rebuilding load. A brace may provide temporary support for some people, but it does not replace addressing strength, function, and load tolerance over time.
References
- https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136375
- https://orthopedicreviews.openmedicalpublishing.org/article/37471-comparative-effectiveness-of-sacroiliac-belt-versus-lumbar-orthosis-utilization-on-nonspecific-low-back-pain-a-crossover-randomized-clinical-trial
- https://journal.parker.edu/article/78033-controlled-trial-of-sacroiliac-belt-impact-on-spine-pain-regional-thigh-discomfort-and-erector-spinae-flexion-relaxation-phenomenon-following-a-manu
- https://journals.sagepub.com/doi/full/10.1177/0309364616640873
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298339/
- https://journals.sagepub.com/doi/10.1177/03635465251388408
- https://academic.oup.com/jhps/article/12/Supplement_1/i48/8099780
- https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.888775/full
- https://link.springer.com/article/10.1186/s12891-026-09587-2

